{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:00:38Z","timestamp":1781650838295,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"DOI":"10.1186\/s40780-026-00574-2","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:46:19Z","timestamp":1777297579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug-drug interaction signals between carbonic anhydrase inhibitors and vitamin D preparations in urinary tract stones: disproportionality analysis evaluation from Japanese spontaneous reports of adverse events"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-5733","authenticated-orcid":false,"given":"Teruhisa","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1456-7721","authenticated-orcid":false,"given":"Yuki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0001-2517","authenticated-orcid":false,"given":"Yuka","family":"Sakazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9442-4469","authenticated-orcid":false,"given":"Yoichi","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"574_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1053\/j.ajkd.2024.12.009","volume":"6","author":"BR Salka","year":"2025","unstructured":"Salka BR, Oerline MK, Yan P, Hsi RS, Crivelli JJ, Asplin JR, et al. Associations of topiramate and zonisamide use with kidney stones: a retrospective cohort study. Am J Kidney Dis. 2025;6:687\u201394.","journal-title":"Am J Kidney Dis"},{"key":"574_CR2","doi-asserted-by":"publisher","unstructured":"Alexander RT, Dimke H. Effect of diuretics on renal tubular transport of calcium and magnesium. Am J Physiol-Renal Physiol. 2017;312(6):F998\u20131015. https:\/\/doi.org\/10.1152\/ajprenal.00032.2017.","DOI":"10.1152\/ajprenal.00032.2017"},{"key":"574_CR3","first-page":"949","volume":"54","author":"H Sohn","year":"1978","unstructured":"Sohn H, Ikeda H, Unakami H, Hurukawa Y. Parathyroid hormone-like effects of acetazolamide (author\u2019s transl). Nihon Naibunpi Gakkai Zasshi. 1978;54:949\u201356.","journal-title":"Nihon Naibunpi Gakkai Zasshi"},{"issue":"1","key":"574_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1590\/1678-4685-jbn-2018-00010002","volume":"40","author":"MJ Carvalho","year":"2018","unstructured":"Carvalho MJ. Urinary pH in calcium oxalate stone formers: does it matter? J Bras Nefrol. 2018;40(1):6\u20137. https:\/\/doi.org\/10.1590\/1678-4685-jbn-2018-00010002.","journal-title":"J Bras Nefrol"},{"issue":"4","key":"574_CR5","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/archopht.1958.00940050092011","volume":"59","author":"A Shah","year":"1958","unstructured":"Shah A, Constant MA, Becker B. Urinary excretion of citrate in humans following administration of acetazolamide (diamox). Archives Ophthalmol. 1958;59(4):536\u201340. https:\/\/doi.org\/10.1001\/archopht.1958.00940050092011.","journal-title":"Archives Ophthalmol"},{"issue":"26","key":"574_CR6","first-page":"1332","volume":"89","author":"HW Mcintosh","year":"1963","unstructured":"Mcintosh HW, Seraglia M, Uhlemann I, Kore R. Effect of acetazolamide and triple sulfonamide on citrate and calcium excretion. Can Med Assoc J. 1963;89(26):1332\u201333.","journal-title":"Can Med Assoc J"},{"key":"574_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/MNH.0000000000000474","volume":"28","author":"JD Rimer","year":"2019","unstructured":"Rimer JD, Sakhaee K, Maalouf NM. Citrate therapy for calcium phosphate stones. Curr Opin ephrol Hypertens. 2019;28:130\u201339.","journal-title":"Curr Opin ephrol Hypertens"},{"issue":"5","key":"574_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1600-0404.2005.00474.x","volume":"112","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P. Epilepsy, osteoporosis and fracture risk - a meta-analysis. Acta Neurol Scand. 2005;112(5):277\u201386. https:\/\/doi.org\/10.1111\/j.1600-0404.2005.00474.x.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"574_CR9","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/epi4.12776","volume":"8","author":"M Babunovska","year":"2023","unstructured":"Babunovska M, Jovanovski A, Boskovski B, Foteva M, Kuzmanovski I, Trencevska GK, et al. Fractures in people with epilepsy: a nationwide population-based cohort study. Epilepsia Open. 2023;8(3):1028\u201337. https:\/\/doi.org\/10.1002\/epi4.12776.","journal-title":"Epilepsia Open"},{"issue":"4","key":"574_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/epi.14015","volume":"59","author":"H Fernandez","year":"2018","unstructured":"Fernandez H, Mohammed HT, Patel T. Vitamin D supplementation for bone health in adults with epilepsy: a systematic review. Epilepsia. 2018;59(4):885\u201396. https:\/\/doi.org\/10.1111\/epi.14015.","journal-title":"Epilepsia"},{"issue":"2","key":"574_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00774-012-0397-6","volume":"31","author":"H Hagino","year":"2013","unstructured":"Hagino H, Takano T, Fukunaga M, Shiraki M, Nakamura T, Matsumoto T. Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis. J Bone Min Metab. 2013;31(2):183\u201389. https:\/\/doi.org\/10.1007\/s00774-012-0397-6.","journal-title":"J Bone Min Metab"},{"issue":"10\u201311","key":"574_CR12","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.clinbiochem.2011.04.017","volume":"44","author":"SM Kimball","year":"2011","unstructured":"Kimball SM, Burton JM, O\u2019Connor PG, Vieth R. Urinary calcium response to high dose vitamin D3 with calcium supplementation in patients with multiple sclerosis. Clin Biochem. 2011;44(10\u201311):930\u201332. https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.04.017.","journal-title":"Clin Biochem"},{"issue":"1","key":"574_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1258\/acb.2007.007074","volume":"45","author":"S Kimball","year":"2008","unstructured":"Kimball S, Vieth R. Self-prescribed high-dose vitamin D3: effects on biochemical parameters in two men. Ann Clin Biochem. 2008;45(1):106\u201310. https:\/\/doi.org\/10.1258\/acb.2007.007074.","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"574_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/jop.1997.13.23","volume":"13","author":"TH Maren","year":"1997","unstructured":"Maren TH, Conroy CW, Wynns GC, Levy NS. Ocular absorption, blood levels, and excretion of dorzolamide, a topically active carbonic anhydrase inhibitor. J Ocul Pharmacol Th. 1997;13(1):23\u201330. https:\/\/doi.org\/10.1089\/jop.1997.13.23.","journal-title":"J Ocul Pharmacol Th"},{"key":"574_CR15","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3389\/fphar.2019.01319","volume":"10","author":"Y Noguchi","year":"2019","unstructured":"Noguchi Y, Tachi T, Teramachi H. Review of statistical methodologies for detecting drug\u2013drug interactions using spontaneous reporting systems. Front Pharmacol. 2019;10:1319. https:\/\/doi.org\/10.3389\/fphar.2019.01319.","journal-title":"Front Pharmacol"},{"issue":"6","key":"574_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1046\/j.1365-2125.1999.00957.x","volume":"47","author":"EP Van Puijenbroek","year":"1999","unstructured":"Van Puijenbroek EP, Egberts ACG, Meyboom RHB, Leufkens HGM. Signalling possible drug\u2013drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. Brit J Clin Pharma. 1999;47(6):689\u201393. https:\/\/doi.org\/10.1046\/j.1365-2125.1999.00957.x.","journal-title":"Brit J Clin Pharma"},{"issue":"9","key":"574_CR17","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00228-015-1898-8","volume":"71","author":"H Li","year":"2015","unstructured":"Li H, Deng J, Yue Z, Zhang Y, Sun H. Detecting drug\u2013herbal interaction using a spontaneous reporting system database: an example with benzylpenicillin and qingkailing injection. Eur. J. Clin. Pharmacol. 2015;71(9):1139\u201345. https:\/\/doi.org\/10.1007\/s00228-015-1898-8.","journal-title":"Eur. J. Clin. Pharmacol"},{"key":"574_CR18","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3389\/fphar.2019.00874","volume":"10","author":"I Inaba","year":"2019","unstructured":"Inaba I, Kondo Y, Iwasaki S, Tsuruhashi S, Akaishi A, Morita K, et al. Risk evaluation for acute kidney injury induced by the concomitant use of valacyclovir, analgesics, and renin\u2013angiotensin system inhibitors: the detection of signals of drug\u2013drug interactions. Front Pharmacol. 2019;10:874. https:\/\/doi.org\/10.3389\/fphar.2019.00874.","journal-title":"Front Pharmacol"},{"issue":"1","key":"574_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/ndt\/gfac037","volume":"38","author":"PM Ferraro","year":"2022","unstructured":"Ferraro PM, Taylor EN, Curhan GC. Factors associated with sex differences in the risk of kidney stones. Nephrol Dial Transpl. 2022;38(1):177.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"574_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1590\/s1677-5538.ibju.2019.0278","volume":"46","author":"S Wang","year":"2020","unstructured":"Wang S, Zhang Y, Zhang X, Tang Y, Li J. Upper urinary tract stone compositions: the role of age and gender. Int braz j Urol. 2020;46(1):70. https:\/\/doi.org\/10.1590\/s1677-5538.ibju.2019.0278.","journal-title":"Int braz j Urol"},{"issue":"3","key":"574_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/nu10030366","volume":"10","author":"E Letavernier","year":"2018","unstructured":"Letavernier E, Daudon DM. Vitamin D, Hypercalciuria and Kidney Stones. Nutrients. 2018;10(3):366. https:\/\/doi.org\/10.3390\/nu10030366.","journal-title":"Nutrients"},{"key":"574_CR22","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.3390\/nu13124363","volume":"13","author":"M Bargagli","year":"2021","unstructured":"Bargagli M, Ferraro PM, Vittori M, Lombardi G, Gambaro G, Somani B. Calcium and vitamin D supplementation and their association with kidney stone disease: a narrative review. Nutrients. 2021;13:4363.","journal-title":"Nutrients"},{"key":"574_CR23","doi-asserted-by":"publisher","unstructured":"Wang K, Ge J, Han W, Wang D, Zhao Y, Shen Y, et al. Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis. BMC Urol. 2022;22(1). https:\/\/doi.org\/10.1186\/s12894-022-01017-4.","DOI":"10.1186\/s12894-022-01017-4"},{"issue":"1","key":"574_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12894-021-00905-5","volume":"21","author":"P Khalili","year":"2021","unstructured":"Khalili P, Jamali Z, Sadeghi T, Esmaeili-Nadimi A, Mohamadi M, Moghadam-Ahmadi A, et al. Risk factors of kidney stone disease: a cross-sectional study in the southeast of Iran. BMC Urol. 2021;21(1):141. https:\/\/doi.org\/10.1186\/s12894-021-00905-5.","journal-title":"BMC Urol"},{"issue":"1","key":"574_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.eururo.2009.03.031","volume":"56","author":"HA Fink","year":"2009","unstructured":"Fink HA, Akornor JW, Garimella PS, MacDonald R, Cutting A, Rutks IR, et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urology. 2009;56(1):72\u201380. https:\/\/doi.org\/10.1016\/j.eururo.2009.03.031.","journal-title":"Eur Urology"},{"issue":"3","key":"574_CR26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0022-5347(01)66321-3","volume":"155","author":"L Borghi","year":"1996","unstructured":"Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155(3):839\u201343. https:\/\/doi.org\/10.1016\/S0022-5347(01)66321-3.","journal-title":"J Urol"},{"key":"574_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.euf.2017.04.001","volume":"3","author":"OA Raheem","year":"2017","unstructured":"Raheem OA, Khandwala YS, Sur RL, Ghani KR, Denstedt JD. Burden of urolithiasis: trends in prevalence, treatments, and costs. Eur Urol Focus. 2017;3:18\u201326.","journal-title":"Eur Urol Focus"},{"issue":"1","key":"574_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/ki.2012.320","volume":"83","author":"VO Edvardsson","year":"2013","unstructured":"Edvardsson VO, Indridason OS, Haraldsson G, Kjartansson O, Palsson R. Temporal trends in the incidence of kidney stone disease. Kidney Int. 2013;83(1):146\u201352. https:\/\/doi.org\/10.1038\/ki.2012.320.","journal-title":"Kidney Int"},{"issue":"7","key":"574_CR29","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2215\/CJN.13251215","volume":"11","author":"CD Scales","year":"2016","unstructured":"Scales CD, Tasian GE, Schwaderer AL, Goldfarb DS, Star RA, Kirkali Z. Urinary stone disease: advancing knowledge, patient care, and population health. CJASN. 2016;11(7):1305\u201312. https:\/\/doi.org\/10.2215\/CJN.13251215.","journal-title":"CJASN"},{"issue":"4","key":"574_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/01.mnh.0000447017.28852.52","volume":"23","author":"X Tang","year":"2014","unstructured":"Tang X, Lieske JC. Acute and chronic kidney injury in nephrolithiasis. Curr Opin Nephrol Hypertens. 2014;23(4):385\u201390. https:\/\/doi.org\/10.1097\/01.mnh.0000447017.28852.52.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"574_CR31","doi-asserted-by":"publisher","first-page":"1339276","DOI":"10.3389\/fneur.2024.1339276","volume":"15","author":"ML Gaertner","year":"2024","unstructured":"Gaertner ML, Mintzer S, DeGiorgio CM. Increased cardiovascular risk in epilepsy. Front Neurol. 2024;15:1339276. https:\/\/doi.org\/10.3389\/fneur.2024.1339276.","journal-title":"Front Neurol"},{"issue":"8","key":"574_CR32","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1007\/s00345-020-03564-7","volume":"39","author":"E Brain","year":"2021","unstructured":"Brain E, Geraghty RM, Cook P, Roderick P, Somani B. Risk of UTI in kidney stone formers: a matched-cohort study over a median follow-up of 19 years. World J Urol. 2021;39(8):3095\u2013101. https:\/\/doi.org\/10.1007\/s00345-020-03564-7.","journal-title":"World J Urol"},{"issue":"1","key":"574_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40264-024-01473-x","volume":"48","author":"Y Noguchi","year":"2025","unstructured":"Noguchi Y, Tachi T, Yoshimura T. Caveats of covariate adjustment in disproportionality analysis for best practices. Drug Saf. 2025;48(1):1\u20135. https:\/\/doi.org\/10.1007\/s40264-024-01473-x.","journal-title":"Drug Saf"}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-026-00574-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-026-00574-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-026-00574-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:48:59Z","timestamp":1781650139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40780-026-00574-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1186\/s40780-026-00574-2","relation":{},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The JADER dataset used in this study contained anonymized processed information in accordance with Japan\u2019s Personal Information Protection Law. Furthermore, according to the ethical guidelines for clinical research in Japan, studies utilizing anonymized processed information do not require review by an ethical review committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This manuscript was entirely written by the authors without the aid of any AI assistant tools.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"56"}}